3,4-dihydroxyphenylacetic acid has been researched along with Colonic Neoplasms in 3 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In vitro treatment of HCT-116 colon cancer cells with 3,4-DHPAA and EGCG exhibited an additive antiproliferative effect, while methylation of 3,4-DHPAA was significantly decreased." | 2.78 | Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer. ( Abgaryan, N; Aronson, WJ; Carpenter, CL; de Oliveira, DM; Heber, D; Henning, SM; Lee, RP; Vicinanza, R; Wang, P; Zhang, Y, 2013) |
| "Bisphenol A (BPA) promotes colon cancer by altering the physiological functions of hormones." | 1.91 | Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. ( Campos-Vega, R; García-Gutiérrez, N; García-Solis, P; Herrera-Hernández, G; Lozano-Herrera, SJ; Luna-Bárcenas, G; Sánchez-Tusié, AA; Vergara-Castañeda, HA, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| García-Gutiérrez, N | 1 |
| Luna-Bárcenas, G | 1 |
| Herrera-Hernández, G | 1 |
| Campos-Vega, R | 1 |
| Lozano-Herrera, SJ | 1 |
| Sánchez-Tusié, AA | 1 |
| García-Solis, P | 1 |
| Vergara-Castañeda, HA | 1 |
| Catalán, M | 1 |
| Ferreira, J | 1 |
| Carrasco-Pozo, C | 1 |
| Henning, SM | 1 |
| Wang, P | 1 |
| Abgaryan, N | 1 |
| Vicinanza, R | 1 |
| de Oliveira, DM | 1 |
| Zhang, Y | 1 |
| Lee, RP | 1 |
| Carpenter, CL | 1 |
| Aronson, WJ | 1 |
| Heber, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Non Digestible Carbohydrate on Production of Phenolic Acids From Strawberry Juice[NCT03383809] | 15 participants (Actual) | Interventional | 2017-04-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3,4-dihydroxyphenylacetic acid and Colonic Neoplasms
| Article | Year |
|---|---|
Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy | 2013 |
2 other studies available for 3,4-dihydroxyphenylacetic acid and Colonic Neoplasms
| Article | Year |
|---|---|
Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antioxidants; Benzhydryl Compounds; Cell Proliferation; Colonic Neop | 2023 |
The Microbiota-Derived Metabolite of Quercetin, 3,4-Dihydroxyphenylacetic Acid Prevents Malignant Transformation and Mitochondrial Dysfunction Induced by Hemin in Colon Cancer and Normal Colon Epithelia Cell Lines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antineoplastic Agents; Apoptosis; Biological Products; Cell | 2020 |